Skip to content

FDA drug label d4f445c2: US FDA label indications

US FDA labelNot medical advice

Indications and usage (label excerpt)

INDICATIONS AND USAGE Morphine Sulfate Injection is a potent analgesic used to relieve severe, acute pain or severe, chronic pain (e.g., in terminally ill patients). The drug is also used parenterally for preoperative sedation, as a supplement to anesthesia and for analgesia during labor. Morphine is used in patients with acute pulmonary edema for its cardiovascular effects and to allay anxiety. Morphine should not be used in the treatment of pulmonary edema resulting from a chemical respiratory irritant. Morphine is the drug of choice in relieving pain of myocardial infarction.

Warnings (label excerpt)

WARNINGS Morphine Sulfate Injection may be habit forming (see DRUG ABUSE AND DEPENDENCE ). Overdoses may cause respiratory depression, coma and death (see OVERDOSAGE ). Do not use injection if it contains a precipitate. Head Injury and Increased Intracranial Pressure The respiratory-depressant effects of morphine and its capacity to elevate cerebrospinal fluid pressure may be markedly exaggerated in the presence of head injury, other intracranial lesions or a preexisting increase in intracranial pressure. Furthermore, narcotics produce adverse reactions which may obscure the clinical course of patients with head injuries. In such patients, morphine must be used with extreme caution and only if its use is deemed essential. Asthma and Other Respiratory Conditions Morphine should be used with extreme caution in patients having an acute asthmatic attack, in patients with chronic obstructive pulmonary disease or cor pulmonale, patients having a substantially decreased respiratory reserve, a…

Excerpts are shortened. Read the full label, and ask a pharmacist or prescriber about any medicine. Full label on DailyMed(opens in a new tab) For products sold in Canada, see the Health Canada Drug Product Database(opens in a new tab).

Source: openFDA drug label (US FDA), snapshot October 2026. Not a Health Canada Product Monograph.